Skip to main content
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology logoLink to Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
. 2023 May 2;19:36. doi: 10.1186/s13223-023-00786-3

Rare and heterogeneous manifestations of leucocyte adhesion deficiency type 1: report of two cases with diagnostic dilemmas and novel ITGB2 mutation

Sabiha Anis 1,, Aiysha Abid 2, Sadaf Aba Umer Kodwavwala 3, Sabahat Sarfaraz 4, Samina Junejo 5, Saba Shahid 5, Sajid Sultan 3, Adibul Hasan Rizvi 6
PMCID: PMC10155398  PMID: 37131167

Abstract

Background

Primary immunodeficiency disorders (PID) are rare disorders with heterogeneous manifestations, overlapping with other diseases such as autoimmunity, malignancy, and infections. This makes the diagnosis very challenging and delays management. Leucocyte adhesion defects (LAD) are a group of PIDs in which patients lack adhesion molecules on leukocytes needed for their emigration through blood vessels to the site of infection. Patients with LAD can present with diverse clinical features including severe and life-threatening infections, early in life, and the absence of pus formation around infection or inflammation. There is often delayed umbilical cord separation, omphalitis, late wound healing, and a high white blood cell count. If not recognized and managed early, can lead to life-threatening complications and death.

Case Presentation

LAD 1 is characterized by homozygous pathogenic variants in the integrin subunit beta 2 (ITGB2) gene. We report two cases of LAD1 with unusual presentations (post-circumcision excessive bleeding and chronic inflammation of the right eye) which were confirmed by flow cytometric analysis and genetic testing. We found two disease-causing ITGB2 pathogenic variants in both cases.

Conclusions

These cases highlight the importance of a multidisciplinary approach to recognizing clues in patients with uncommon manifestations of a rare disease. This approach initiates a proper diagnostic workup of primary immunodeficiency disorder leading to a better understanding of the disease, and appropriate patient counseling, and helps clinicians to be better equipped to deal with complications.

Keywords: Primary immunodeficiency. Leucocyte adhesion defect, Novel ITGB2 variants, High TLC counts

Background

Primary immunodeficiency disorders (PID) are rare diseases with an overall global prevalence of 0.02–0.1%. There are more than 400 PIDs that have been identified so far. The clinical features of these disorders are mostly non-specific and overlap with features of infections, autoimmunity, inflammation, allergies, malignancies, etc. [1]. Because of the overlapping symptoms and lack of awareness about these rare disorders, there is a tendency to miss these diseases and thus hampers or delays proper patient management [2].

Leucocyte adhesion defects (LAD) are a group of PIDs, characterized by the absence of adhesion molecules on leucocytes resulting in an inability to migrate to the site of infection and inflammation. This results in recurrent severe infections, mostly early in life, leading to failure to thrive and death if not recognized and managed early [3, 4]. LADs are classified into types-I, II, and III, categorized by the presence of homozygous pathogenic variants in the ITGB2, SLC35C1, and FERMT3 genes, respectively [3, 58]. Recently a type 4 LAD has been described as characterized by pathogenic variants in the transmembrane conductance regulator (CFTR) gene. In LAD 4, the defects are present mainly in monocytes, unlike in LAD I-III, where the main defects are in the neutrophils [3, 9]. LAD can be presented with diverse clinical features. However, the common features in all cases are characterized by a high total leucocyte count (TLC) count in the blood due to their inability to move out to the site of infection and the absence of pus formation around infection or inflammation [6, 10].

Here we report two cases of leukocyte adhesion deficiency type1 with heterogeneous manifestations. The first case was a four-month-old boy, who presented to us with post-circumcision bleeding and did not respond to surgical measures. The second case was of an eight months old female child who presented with a granulomatous lesion of the right eye with a novel homozygous disease-causing variant identified in the ITGB2 gene.

Case presentations

Four-month-old

A four-month-old child presented with delayed wound healing post-circumcision and sepsis. During the hospital stay, he developed multiple necrotic lesions around the perineum, thighs, gluteal region, and neck (Fig. 1). On examination, he was anemic and febrile with a temperature of 39°C. There was no pus formation in and around the wounds and the penis had sloughed off. The wound swab culture grew Klebsiella species and Acinetobacter. During admission, the patient also developed an ear infection. Ear discharge and blood cultures grew pseudomonas. There was no hepatosplenomegaly or lymphadenopathy and no abnormality was found in the rest of the clinical examination, including the respiratory system, cardiovascular system, and nervous system.

Fig. 1.

Fig. 1

Non-healing ulcers on gluteal regions of patient

Because of non-healing wounds and sepsis, a multidisciplinary action was taken involving infectious disease specialists and immunologists, and pediatric urologists.

Further history revealed that he was born of consanguineous marriage at full term by the caesarian section. He was the second child in the family and was breastfeeding. The umbilical cord of this child was separated on the 22nd day of birth and there was no omphalitis.

One elder sister died at the age of 2.5 years due to sepsis after receiving Bacillus Calmette Guerin (BCG) vaccination. According to the parents, she developed an infection of BCG scar which later on evolved into sepsis and gangrene of the hand, eventually causing the death of the child. Because of this family history and clinical presentation, this patient was not vaccinated.

Considering non-healing wounds and severe difficult-to-treat infections, and suggestive family history, a work-up for immunodeficiency was initiated. A preliminary suspicion of primary immunodeficiency included chronic granulomatous disease, IFN-γ-IL-12 axis defect, leukocyte adhesion deficiency (LAD), and Chediak Higashi syndrome. Other immunodeficiencies were also considered initially but with very low probability including cellular immunodeficiency and antibody deficiency. Initial investigations showed normal levels of immunoglobulin (IgG, IgM, and IgA) and slightly raised IgE (Table 1). His total leucocyte count was very high with relative neutrophilia. Accordingly, all lymphocyte subsets (T, B, and NK) were also increased (Table 1). The neutrophil function test was negative by both the nitroblue tetrazolium slide test (NBT) and dihydro rhodamine (DHR) assay by flow cytometry (Table 2 and Fig. 2a). Flow cytometric analysis for adhesion molecules showed a complete absence (< 1%) of CD11 and CD18 on granulocytes consistent with leucocyte adhesion deficiency type 1 (LAD1) (Fig. 2b). Therefore, the ITGB2 gene was screened for a pathogenic gene variant. A homozygous likely pathogenic variant (c.817G > A; p. Val273Met) was identified confirming type 1 LAD.

Table 1.

Laboratory test results

a. Case 1

Age: four months
Hematological Parameter Reference ranges
Hemoglobin level 8.6 g/dl 11.1–16.3 g/dl
Total Leucocyte Count 119 x 103 cells/µl 4–10 x 103 cells/µl
Neutrophils 82% (97.5 103/ µl) 40–80% (2–7 x 103 cells/µl)
Lymphocytes 11% (13.1 103/ µl) 20–40% (1–3 x 103 cells/µl)
Monocytes 7% (8.3103/ µl) 2–10% (0.2-1 103 cells/µl)
Platelets 94 x 103/ µl 150-410x 103 cells/µl
Peripheral film: Normochromic, leukocytosis with predominant neutrophilia Normochromic, Normocytic
Blood group: B Positive
Immunological Work-up Reference range
Serum Immunoglobulins (Ig)
IgG 10.5 2.3 to 14.1 g/l
IgA 1.19 0-0.83 g/l
IgM 2.00 0-1.45 g/l
IgE 272 < 100 IU/ml
Neutrophil Function test:
NBT1 slide test No abnormality detected
Dihydrorhodamine (DHR) Test Stimulation Index (SI) = 400 (Control = 200)
Lymphocyte subset analysis: % Ratio Cells/µl % Ratio Cells/µl
Total CD3+ T cells 72 8251 57 to 81 1000 to 4900
CD3+CD4+ (helper) T cells 46 5272 24 to 47 500 to 2700
CD3+CD8+ (cytotoxic) T cells 27 3094 17 to 37 300 to 2100
CD16+56+ (NK2) cells 14 1604 8 to 28 200 to 900
CD 19+ (B) cells 14 1604 10 to 27 200 to 2200
Flow cytometric analysis for CD11/CD18 expression of CD11b, CD11c, and CD18 was less than 1% on the patient’s neutrophils.
Other tests:
C-reactive Protein-H (CRP-H) 35 mg/dl < 0.744 mg/dl
Anti-HIV3-IgG Negative Negative
Anti-HCV4-IgG Negative Negative
Mutation analysis for beta 2 integrin gene Homozygous variant in ITGB2 (c.817G > A) gene, reported being pathogenic according to HGMD-public database.
Table 2.

Laboratory test results

b. Case 2

Age: two years and eight months
Hematological Parameter Reference range
Hemoglobin level 5.6 g/dl 11.1–16.3 g/dl
Total Leucocyte Count 142 x 103 cells/µl 4–10 x 103 cells/µl
Neutrophils 87% (124 x 103 cells / µl) 40–80% (2–7 x 103 cells/µl)
Lymphocytes 10% (14.2x103 cells / µl) 20–40% (1–3 x 103 cells/µl)
Monocytes 0 2–10% (0.2-1x 103 cells/µl)
Eosinophils 1% (1.4x103 cells / µl) 1–6% (0.02–0.5 x 103 cells/µl)
Platelets 94 x 103 cells / µl 150-410x 103 cells/µl
Peripheral film: hypochromic, anisocytosis, leukocytosis with neutrophilia Normochromic and normocytic
Blood group: O positive
Immunological Work-up Reference range
Serum Immunoglobulins (Ig):
IgG 9.5 2.3 to 14.1 g/l
IgA 0.9 0-0.83 g/l
IgM 1.5 0-1.45 g/l
IgE 476 < 100 IU/ml
Complements (C)
C3 0.8 0.8–1.73 g/l
C4 0.19 0.13–0.47 g/l
Lymphocyte subset analysis: % Ratio Cells/µl % Ratio Cells/µl
Total CD3+ T cells 57 8580 57 to 81 1000 to 4900
CD3+CD4+ (helper) T cells 36.7 5580 24 to 47 500 to 2700
CD3+CD8+ (cytotoxic) T cells 17.5 2670 17 to 37 300 to 2100
CD16+56+ (NK1) cells 10.1 1540 8 to 28 200 to 900
CD 19+ (B) cells 31.4 4780 10 to 27 200 to 2200
Flow cytometric analysis for CD11/CD18 expression of CD11c, and CD18 were less than 1% on the patient’s neutrophils, while expression of CD11b was 74%
Other tests:
C-reactive Protein-H (CRP-H) 35 mg/dl < 05 mg/dl
Anti-HIV2-IgG Negative Negative
Anti-HCV3-IgG Negative Negative
Mutation analysis for beta 2 integrin gene A homozygous splice-site variant (c.994–1G > C) was detected in the patient.

Abbreviations: HCV = hepatitis C Virus, HIV = human immunodeficiency virus, NK = Natural killer, NBT = nitroblue tetrazolium

Fig. 2.

Fig. 2

Flow cytometric analysis

a: Dihydrorhodamine assay by flowcytometry showing normal oxidative burst by neutrophils There is a normal shift from baseline after stimulation in the patient compared to healthy control and the patient’s mother’s leucocytes. The Stimulation index of neutrophils after stimulation Vs. unstimulated cells were more than 100 in healthy control, mother, and patient.

b: Flow cytometric analysis of leukocyte adhesion molecules (CD11b, CD11c, CD18). Expression of CD11b, CD11c and Cd18 was absent (<1%) on granulocytes in case 1, and in case 2, there is absence (<1%) of CD11c and CD18 the patient?s granulocytes, while expression of CD11b was 74%

The patient was rigorously managed surgically and medically. Hemostatic suturing of bleeders was applied at the penile shaft and daily dressing was done. He was given broad-spectrum intravenous antibiotics and an injection of vitamin K. Blood and platelets were also transfused. He was subsequently discharged on oral antibiotics. At the time of discharge, his hemoglobin was 10.6 mg/dl, TLC was 59 × 103 cells/ µl and platelets were 244 × 103/µl. Parents were counseled to maintain strict hygiene, regular follow-up, and prenatal diagnosis in a subsequent pregnancy. They have also advised bone marrow transplantation of their child.

Two years and eight months old

Two years and eight-month-old female child presented with right eye swelling. It started as a pustule on the right eyelid two months back. There is an associated high-grade fever. On examination, the patient was febrile and irritable. The right eye was red and swollen and almost closed with a scab formation. The chest was clear and the abdomen was soft with no visceromegaly but there was a reducible umbilical hernia. CT scan and MRI brain findings were consistent with a large heterogenous abscess in the inferior margin of the right globe extending into the right intraconal component which can be due to chronic granulomatous infections such as mycobacterium tuberculosis (MTB) or fungal infections The lesion did not involve maxillary bones and was confined to the soft tissues of the orbit. Paranasal sinuses were clear. An excision biopsy of the lesion confirmed abscess formation but was negative for fungal infections. The smear was negative for acid-fast bacilli and MTB was not detected in the pus by GeneXpert testing. Cultures from the wound showed Pseudomonas aeruginosa. Blood cultures were negative. The child was put on ciprofloxacin and voriconazole.

Further history revealed delayed shedding of the umbilical cord at one month of age but there was no omphalitis. She was born of consanguineous marriage and was vaccinated only for BCG after which she developed a high-grade fever. Family history was significant for a death of a sibling (male) at 8 months of age 5 years back due to sepsis. He had omphalitis and a severe reaction to BCG vaccination. One sister (7 years) and one brother (2 years) are alive and healthy.

Complete blood counts showed a very high TLC (142 × 103/µl) with predominant neutrophilia. Considering the significant history of infections, reaction to BCG vaccination, family history of the death of a sibling, and a very high TLC count, an immunodeficiency workup was initiated. Serum Immunoglobulins and complement levels (C3 and C4) were normal. Lymphocyte subset analysis showed high counts of all lymphocytes including T cells, B cells, and NK cells. (Table 1b). Flow cytometric analysis for CD11/CD18 showed a complete absence of CD11c and CD18 (< 1%) on the patient’s granulocytes (Fig. 2b). Genetic analysis showed a novel homozygous splice-site pathogenic variant (c.994‒1G > C), consistent with the diagnosis of leukocyte adhesion deficiency type 1 (LAD 1) (Table 2 and Fig. 3).

Fig. 3.

Fig. 3

ITGB2 gene screening for Leukocyte adhesion deficiency type 1 showing c.994‒1G > C variant

The patient was treated vigorously for infections with vancomycin, voriconazole, and cefixime. Her wound became slightly better, her fever subsided and TLC counts dropped to 50 × 103/µl.

Discussion and conclusions

PIDs are very rare disorders with heterogeneous manifestations. The main clinical features of these disorders are recurrent severe infections, and the diagnosis is often missed or delayed. Moreover, genetic testing is often required to make a definite diagnosis [3, 4].

PIDs are classified according to the defects in cells or molecules and the resulting phenotypes [1]. LAD is characterized by severe and recurrent infections due to defective chemotaxis of leucocytes. The migration of leucocytes along blood vessel walls and their emigration to the site of injury involves various sets of adhesion molecules. These molecules are expressed on both resting and stimulated endothelial cells and leucocytes. Depending upon the defect in the expression of different adhesion molecules, LAD is categorized into LAD I to III. In LAD I there is a defect in ß2 integrins on leucocytes, In LAD II, there is the absence of fucosylated ligands for selectins, and in LAD III, ß2 integrins are present but functionally defective [5, 8].

The defect in LAD I is due to biallelic loss of the ITGB2 gene, encoding the β2 subunit of integrin. This leads to decreased expression of CD11a (αLβ2, LFA-1), CD11b (αMβ2, Mac-1), CD11c (αXβ2), and CD11d (αDβ2) integrins on leucocytes that hampers their migration to the site of infection or inflammation in the tissues from blood [3, 8, 12]. As a result, there are recurrent infections, especially bacterial and fungal infections of varying severity, non-healing wounds without pus formation, and early death usually in infancy [3, 8]. There is often a history of delayed separation of the umbilical cord and omphalitis [3, 8, 1113]. More than 150 gene variants have been identified in patients with LAD1 (OMIM # 600,065) including gross deletion, insertion, nonsense, and missense variants, etc. that were usually found pathogenic [6, 11, 2123]. The product of this gene belongs to the integrin beta chain family of proteins, known to participate in cell adhesion as well as cell-surface mediated signaling. The variant c.817G > A; p.G273R identified in the first case has been reported previously in a patient with a moderately severe phenotype of LAD-1 [24]. The variant is located in the conserved B2 subunit domain leads to the non-expression of the integrin molecule and affects heterodimer formation. Another likely pathogenic splice-site variant (c.994‒1G > C) in the ITGB2 gene is found in patient 2 (Table 2; Fig. 3). NetGene2 v. 2.4 (http://www.cbs.dtu.dk/services/NetGene2/) bioinformatics tools were employed to assess the pathogenicity of this variant that termed this variant as pathogenic. This variant abolishes the splice junction for exon 8 in the ITGB2 gene and is predicted to cause loss of function. The variant is novel and not reported in the literature or HGMD (Human Gene Mutation Database; http://www.hgmd.org/) but reported in the ClinVar database. This variant is observed in 1/30,616 (0.0032%) alleles from individuals of South Asian background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes databases. According to the ACMG guidelines, the c.994‒1G > C variant is classified as a pathogenic disease-causing. The criteria applied were PVS1 (very strong) applied for null variant (intronic within ± 2 of splice site) in ITGB2 gene, PP5 (moderate) ClinVar classifies this variant as likely pathogenic and PM2 (supporting) either not identified in gnomAD genomes or homozygous allele count less than 2 in gnomAD genomes.

It should be remembered that PIDs have heterogeneous manifestations and therefore requires expertise to recognize these disorders. LADs have a very low prevalence with less than 400 cases reported to date adding to diagnostic dilemmas [14, 15].

In the first case, there was a diagnostic dilemma with impaired wound healing post-circumcision which could have easily been blamed on the surgeon’s unskilled approach. However, a very high TLC count, multiple subsequent infections, and difficult-to-treat wounds led to suspicion of primary immunodeficiency.

Various Eye involvement is known with primary immunodeficiency disorders including antibody deficiencies, severe combined immunodeficiency, neutrophil function defects, complement proteins abnormality, CHARGE syndrome, etc. [16]. In LAD, this is not a typical manifestation and there are only case reports showing necrotizing infection of the eyeball as the presenting feature [17, 18]. However, staphylococcus aureus, pseudomonas, and fungi are common pathogens found in LAD patients [19, 20]. Because of the rarity of this manifestation in LAD, the diagnosis in the second case may have been missed. But a careful history taking into account the consanguinity and a positive family history with a very high leucocyte count triggered the suspicion and further workup for this disorder.

In a Chinese cohort of seven patients, novel mutations were identified in four [25]. Tipu et al. [15] have reported a genetic analysis of 12 Pakistani patients with five pathogenic variants in eight cases and one of the identified variants was novel.

The significance of these case reports lies in the clinical presentation of these children and clues leading to definite diagnoses which otherwise were diagnostic dilemmas. In both cases, there was no omphalitis but there were severe recurrent infections and reactions to BCG vaccination either in the patient or in the siblings who succumbed to intractable infections.

We conclude that in both, cases, the most important lesson learned was a multidisciplinary approach and a low threshold to suspect primary immunodeficiency that leads to a better understanding of the problem. Not only that, the family could be counseled to seek proper treatment and precautionary measures to avoid infections and complications and opt for bone marrow transplantation.

Acknowledgements

We are grateful to.

Prof. Syed Qasim Mehdi, for providing his intellectual input and support for doing genetic testing of the patient.

Prof. Rana Muzaffar for providing us with support towards the diagnostic workup of the patient in her lab.

Dr. Khawar Abbas for arranging flow cytometric analysis of the patient.

Brig. Dr. Tahir Aziz Ahmed, Col. Dr. Dawood Ahmed, and Col.Dr. Hamid Nawaz Tipu of the Armed Forces Institute of Pathology for helping us with flow cytometric analysis of the patients for primary immunodeficiency.

List of Abbreviations

BCG

Bacillus Calmette Guérin

CFTR

Cystic fibrosis transmembrane conductance regulator

CT

Computed tomography

DHR

Dihydrorhodamine

FERMT3

Fermitin family homologue 3

IFN-γ

interferon gamma

IL-12

Interleukin-12

IHHN

Indus Hospital and Health network

ITGB2

integrin subunit beta2

LAD

Leukocyte adhesion defect

LFA-1

Lymphocyte Function Associated Antigen 1

NBT

Nitroblue tetrazolium test

PID

Primary immunodeficiency

SIUT

Sindh Institute of Urology and Transplantation

TLC

total leukocyte count

Author Contribution

SA conceptualize, made the diagnosis, and was involved in the management of the patient and counseling, analyzed the data, wrote the initial draft, and finalized the manuscript. AA was involved in genetic testing and analyzed the data, edited the initial manuscript, and helped in finalizing the draft for submission, SUA was involved in patient management and helped in manuscript editing, SF was involved in the immunological workup and helped in the editing the manuscript, SJ and SSH were involved in patient management and helped in editing the manuscript, SS was involved in supervising primary management and surgical treatment of the patient, counseling of parents and editing of the final draft. AH was involved in supervising diagnostic workup and management and editing of the final draft of the manuscript.

Funding

This work was supported by a core grant to the hospital provided for patient management. There were no other funding resources involved.

Data Availability

All data generated during the study are presented in this article.

Declarations

Ethics approval and consent to participate

As per our Indus Health Network Research center (IHRC), our IRB does not review or approve case reports for 3 or fewer cases as it does not fulfill the criteria for human subject research.

Consent for publication

Written informed consent was obtained from the parents of the subjects presented in this study (as the participants are minors).

Consent for publication

This study was not published earlier or submitted elsewhere while our manuscript is under consideration in the journal of Allergy, Asthma, and Clinical Immunology.

Competing interests

The authors declared that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Sabiha Anis, Email: Sabiha.anis@tih.org.pk, Email: Sabiha_anis@hotmail.com.

Aiysha Abid, Email: aiyshaabid@gmail.com.

Sadaf Aba Umer Kodwavwala, Email: skodwavwala@yahoo.com.

Sabahat Sarfaraz, Email: sabahatzia786@gmail.com.

Samina Junejo, Email: samina.junejo@tih.org.pk.

Saba Shahid, Email: saba.shahid@tih.org.pk.

Sajid Sultan, Email: sajidsultan818@hotmail.com.

Adibul Hasan Rizvi, Email: info@siut.org.

References

  • 1.Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD, Oksenhendler E, Picard C, Puck J, Torgerson TR, Casanova JL, Sullivan KE. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020 Jan;40(1):24–64. DOI: 10.1007/s10875-019-00737-x. Epub 2020 Jan 17. Erratum in: J Clin Immunol. 2020 Feb 22; PMID: 31953710; PMCID: PMC7082301. [DOI] [PMC free article] [PubMed]
  • 2.Pilania RK, Chaudhary H, Jindal AK, Rawat A, Singh S. Current status and prospects of primary immunodeficiency diseases in Asia. Genes Dis. 2019 Sep 12;7(1):3–11. DOI: 10.1016/j.gendis.2019.09.004. PMID: 32181271; PMCID: PMC7063407 [DOI] [PMC free article] [PubMed]
  • 3.Das J, Sharma A, Jindal A, Aggarwal V, Rawat A. Leukocyte adhesion defect: Where do we stand circa 2019? Genes Dis.2019 Aug7;7(1):107–114. DOI: 10.1016/j.gendis.2019.07.012. PMID: 32181281; PMCID: PMC7063431. [DOI] [PMC free article] [PubMed]
  • 4.Nigar S, Khan EA, Ahmad TA. Leukocyte adhesion defect: an uncommon immunodeficiency. J Pak Med Assoc. 2018 Jan;68(1):119–22. PMID: 29371732. [PubMed]
  • 5.Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol. 2010 Feb;38(1):54–60. DOI: 10.1007/s12016-009-8132-3. PMID: 19437145. [DOI] [PubMed]
  • 6.Kambli PM, Bargir UA, Yadav RM, Gupta MR, Dalvi AD, Hule G, Kelkar M, Sawant-Desai S, Setia P, Jodhawat N et al. M. Clinical and Genetic Spectrum of a Large Cohort of Patients with leukocyte adhesion deficiency Type 1 and 3: A multicentric study from India.Front Immunol. 2020 Dec16; 11:612703. DOI: 10.3389/fimmu.2020.612703. PMID: 33391282; PMCID: PMC7772426. [DOI] [PMC free article] [PubMed]
  • 7.Etzioni A. Genetic etiologies of leukocyte adhesion defects. Curr Opin Immunol. 2009 Oct;21(5):481-6. DOI: 10.1016/j.coi.2009.07.005. Epub 2009 Aug 3. PMID: 19647987. [DOI] [PubMed]
  • 8.van de Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, de Boer M, van Leeuwen K, Köker MY, Parvaneh N, Fischer A, Law SK, Klein N, Tezcan FI, Unal E, Patiroglu T, Belohradsky BH, Schwartz K, Somech R, Kuijpers TW, Roos D. Hematologically important mutations: leukocyte adhesion deficiency (first update).Blood Cells Mol Dis. 2012 Jan15;48(1):53–61. DOI: 10.1016/j.bcmd.2011.10.004. Epub 2011 Nov 30. PMID: 22134107; PMCID: PMC4539347. [DOI] [PMC free article] [PubMed]
  • 9.Fan Z, Ley K, Leukocyte Adhesion Deficiency IV. Monocyte Integrin Activation Deficiency in cystic fibrosis. Am J Respir Crit Care Med. 2016 May;15(10):1075–7. 10.1164/rccm.201512-2454ED. PMID: 27174474; PMCID: PMC4872669. [DOI] [PMC free article] [PubMed]
  • 10.Movahedi M, Entezari N, Pourpak Z, Mamishi S, Chavoshzadeh Z, Gharagozlou M, Mir-Saeeid-Ghazi B, Fazlollahi MR, Zandieh F, Bemanian MH, Farhoudi A, Aghamohammadi A. Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). J Clin Immunol. 2007 May;27(3):302-7. DOI: 10.1007/s10875-006-9069-4. Epub 2007 Feb 10. Erratum in: J Clin Immunol. 2008 Jan;28(1):92. Aghamohammadi, Asghar [added]. PMID: 17294145. [DOI] [PubMed]
  • 11.Yaz I, Ozbek B, Bildik HN, Tan C, Oskay Halacli S, Soyak Aytekin E, Esenboga S, Cekic S, Kilic SS, Keskin O, van Leeuwen K, Roos D, Cagdas D, Tezcan I. Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: a multicenter study in Turkey. Clin Exp Immunol. 2021 Oct;206(1):47–55. 10.1111/cei.13645. Epub 2021 Aug 5. PMID: 34310689; PMCID: PMC8446394. [DOI] [PMC free article] [PubMed]
  • 12.De Rose DU, Giliani S, Notarangelo LD, Lougaris V, Lanfranchi A, Moratto D, et al. Long term outcome of eight patients with type 1 leukocyte Adhesion Deficiency (LAD-1): not only infections, but high risk of autoimmune complications. Clin Immunol. 2018 Jun;191:75–80. Epub 2018 Mar 13. PMID: 29548898. [DOI] [PubMed]
  • 13.Wolach B, Gavrieli R, Wolach O, Stauber T, Abuzaitoun O, Kuperman A, Amir Y, Stepensky P, Somech R, Etzioni A. Leucocyte adhesion deficiency-A multicentre national experience. Eur J Clin Invest. 2019 Feb;49(2): e13047. DOI: 10.1111/eci.13047. Epub 2019 Jan 4. PMID: 30412664. [DOI] [PubMed]
  • 14.Almarza Novoa E, Kasbekar S, Thrasher AJ, Kohn DB, Sevilla J, Nguyen T, Schwartz JD, Bueren JA. Leukocyte adhesion deficiency-I: A comprehensive review of all published cases. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1418–1420.e10. DOI: 10.1016/j.jaip.2017.12.008. Epub 2018 Jan 20. PMID: 29371071. [DOI] [PubMed]
  • 15.Nawaz Tipu H, Raza R, Jaffar S, Khan A, Anwar MZ, Ahmad W, Raza SI. β2 Integrin Gene (ITGB2) mutation spectra in Pakistani families with leukocyte adhesion deficiency type 1 (LAD1). Immunobiology. 2020 May;225(3):151938. doi: 10.1016/j.imbio.2020.151938. Epub 2020 Apr 2. PMID: 32279896. [DOI] [PubMed]
  • 16.Hosseinverdi S, Hashemi H, Aghamohammadi A, Ochs HD, Rezaei N. Ocular involvement in primary immunodeficiency diseases. J Clin Immunol. 2014 Jan;34(1):23–38. 10.1007/s10875-013-9974-2. Epub 2013 Nov 30. PMID: 24292697. [DOI] [PubMed]
  • 17.Gupta V, Pandita A, Panghal A, Pillai A. Leucocyte adhesion defect presenting as fulminant sepsis in a new born. BMJ Case Rep. 2019 Aug 30;12(8):e227065. doi: 10.1136/bcr-2018-227065. PMID: 31471353; PMCID: PMC6720668. [DOI] [PMC free article] [PubMed]
  • 18.Ganesh A, Al-Zuhaibi SS, Bialasiewicz AA, Al-Abri R, Ahmed S, Al-Tamemi S, El-Nour IB. Necrotizing Pseudomonas infection of the ocular adnexa in an infant with leukocyte adhesion defect. J Pediatr Ophthalmol Strabismus. 2007 Jul-Aug;44(4):199–200. doi: 10.3928/01913913-20070701-09. PMID: 17694822. [DOI] [PubMed]
  • 19.Rafiei Tabatabaei S, Karimi A, Amanati A, Kazemi Aghdam M, Shamsian BS, et al. Diagnostic dilemma in a patient with chronic fistulating nonhealing Ulcer. Arch Pediatr Infect Dis. 2013;2(3):16471. doi: 10.5812/pedinfect.16471. [DOI] [Google Scholar]
  • 20.Thakur N, Sodani R, Chandra J, Singh V. Leukocyte adhesion defect type 1 presenting with recurrent pyoderma gangrenosum. Indian J Dermatol. 2013 Mar;58(2):158. 10.4103/0019-5154.108076. PMID: 23716823; PMCID: PMC3657233. [DOI] [PMC free article] [PubMed]
  • 21.Hixson P, Smith CW, Shurin SB, Tosi MF. Unique CD18 mutations involving a deletion in the extracellular stalk region and a major truncation of the cytoplasmic domain in a patient with leukocyte adhesion deficiency type 1. Blood. 2004 Feb 1;103(3):1105-13. doi: 10.1182/blood-2003-08-2780. Epub 2003 Sep 25. PMID: 14512306. [DOI] [PubMed]
  • 22.Guan S, Tan SM, Li Y, Torres J, Uzel G, Xiang L, Law SK. Characterization of single amino acid substitutions in the β2 integrin subunit of patients with leukocyte adhesion deficiency (LAD)-1. Blood Cells Mol Dis. 2015 Feb;54(2):177–82. doi: 10.1016/j.bcmd.2014.11.005. Epub 2014 Nov 28. PMID: 25514840. [DOI] [PubMed]
  • 23.Hong S, Xie LJ, Yang QN, Zhu TW. Detection of leukocyte adhesion deficiency type 1 in an infant by highthroughput targeted exome sequencing. J Transl Genet Genom. 2018;2:8. doi: 10.20517/jtgg.2018.06. [DOI] [Google Scholar]
  • 24.Hogg N, Stewart MP, Scarth SL, Newton R, Shaw JM, Law SK, Klein N. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest. 1999;103(1):97–106. doi: 10.1172/JCI3312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sun B, Chen Q, Dong X, Liu D, Hou J, Wang W, Ying W, Hui X, Zhou Q, Yao H, Sun J, Wang X. Report of a Chinese Cohort with Leukocyte Adhesion Deficiency-I and Four Novel Mutations.J Clin Immunol. 2019Apr;39(3):309–315. doi: 10.1007/s10875-019-00617-4. Epub 2019 Mar 27. PMID: 30919141. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated during the study are presented in this article.


Articles from Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology are provided here courtesy of BMC

RESOURCES